VOYAGER THERAPEUTICS INC (VYGR) Stock Balance Sheet
NASDAQ:VYGR - Nasdaq - US92915B1061 - Common Stock - Currency: USD
| MRQ (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 74.75M | 71.37M | 68.80M | 99.00M | 117.40M | |||
| Marketable Securities | 161.26M | 195.32M | 162.07M | 19.90M | 15.10M | |||
| Receivables | 2.11M | 4.49M | 84.45M | 600.00K | 700.00K | |||
| Other Current Assets | 7.08M | 5.63M | 4.35M | 5.00M | 3.40M | |||
| Total Current Assets | 245.21M | 276.81M | 319.68M | 124.50M | 136.70M | |||
| Non-Current Assets | ||||||||
| PPE Net | 46.06M | 47.66M | 30.00M | 33.30M | 55.40M | |||
| Investments And Advances | 59.10M | 65.70M | N/A | N/A | N/A | |||
| Other Non-Current Assets | 2.87M | 2.87M | 1.59M | 1.50M | 1.80M | |||
| Total Non-Current Assets | 108.03M | 116.24M | 31.60M | 34.90M | 57.20M | |||
| TOTAL ASSETS | 353.24M | 393.05M | 351.28M | 159.40M | 193.90M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Accrued Expenses | 16.48M | 21.40M | 20.02M | 10.60M | 19.80M | |||
| Accounts Payable | 2.63M | 4.00M | 1.60M | 2.60M | 600.00K | |||
| Other Current Liabilities | 21.09M | 24.39M | 42.88M | 59.40M | 30.60M | |||
| Total Current Liabilities | 40.21M | 49.79M | 64.51M | 72.60M | 51.00M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Other Non-Current Liabilities | 40.33M | 43.50M | 50.45M | 27.70M | 47.80M | |||
| Total Non-Current Liabilities | 40.33M | 43.50M | 50.45M | 27.70M | 47.80M | |||
| TOTAL LIABILITIES | 80.54M | 93.29M | 114.96M | 100.30M | 98.80M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -357.20M | -326.18M | -261.18M | -393.50M | -347.10M | |||
| Additional Paid In Capital | 630.05M | 626.30M | 497.51M | 452.70M | 442.30M | |||
| Common Shares | 55.00K | 55.00K | 44.00K | 0.00 | 0.00 | |||
| Other Shareholders' Equity | -199.00K | -407.00K | -48.00K | -200.00K | -100.00K | |||
| Shares Outstanding | 55.21M | 54.73M | 44.04M | 38.60M | 37.90M | |||
| Tangible Book Value per Share | 4.94 | 5.48 | 5.37 | 1.53 | 2.51 | |||
| Total Shareholders' Equity | 272.70M | 299.76M | 236.32M | 59.00M | 95.10M | |||
| TOTAL LIABILITIES AND EQUITY | 353.24M | 393.05M | 351.28M | 159.40M | 193.90M | |||
| Statistics | ||||||||
| Current Ratio | 6.10 | 5.56 | 4.96 | 1.71 | 2.68 | |||
| Return On Assets (ROA) | -23.98% | -16.54% | 37.67% | -29.11% | -36.72% | |||
| Return On Equity (ROE) | -31.06% | -21.68% | 56.00% | -78.64% | -74.87% | |||
| Return On Invested Capital (ROIC) | N/A | N/A | 33.61% | N/A | N/A | |||
| Return On Invested Capital Ex Cash (ROICexc) | N/A | N/A | 172.44% | N/A | N/A | |||
| Return On Invested Capital Ex Cash + Goodwill (ROICexcg) | N/A | N/A | 172.44% | N/A | N/A | |||
All data in USD , ROIC based on taxRate of 0.21